BIOMERICA INC (BMRA) Stock Price, Quote, News and Overview
NASDAQ:BMRA - Nasdaq - US09061H3075 - Common Stock - Currency: USD
BMRA Quote, Performance and Key Statistics
0.839
-0.05 (-5.73%)
The current stock price of BMRA is 0.839 USD. In the past month the price increased by 39.39%. In the past year, price decreased by -34.96%.
BMRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About BMRA
Company Profile
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 63 full-time employees. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. The company is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Company Info
BIOMERICA INC
17571 Von Karman Avenue
Irvine CALIFORNIA 92614 US
CEO: Zackary S. Irani
Employees: 64
Company Website: https://biomerica.com/
Investor Relations: http://investors.biomerica.com/overview/default.aspx
Phone: 19493792875
BIOMERICA INC / BMRA FAQ
What is the stock price of BIOMERICA INC today?
The current stock price of BMRA is 0.839 USD. The price decreased by -5.73% in the last trading session.
What is the ticker symbol for BIOMERICA INC stock?
The exchange symbol of BIOMERICA INC is BMRA and it is listed on the Nasdaq exchange.
On which exchange is BMRA stock listed?
BMRA stock is listed on the Nasdaq exchange.
What is BIOMERICA INC worth?
BIOMERICA INC (BMRA) has a market capitalization of 15.39M USD. This makes BMRA a Nano Cap stock.
How many employees does BIOMERICA INC have?
BIOMERICA INC (BMRA) currently has 64 employees.
What are the support and resistance levels for BIOMERICA INC (BMRA) stock?
BIOMERICA INC (BMRA) has a support level at 0.54 and a resistance level at 0.85. Check the full technical report for a detailed analysis of BMRA support and resistance levels.
Should I buy BIOMERICA INC (BMRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BMRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BMRA, evaluating the profitability, health, valuation and growth aspects
- BIOMERICA INC (BMRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOMERICA INC (BMRA) Sales and EPS estimates to see what analysts future expectations are.
- BIOMERICA INC (BMRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOMERICA INC (BMRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOMERICA INC (BMRA) Stock Chart to make your own analysis
- BIOMERICA INC (BMRA) Latest news and press-releases to stay up to date.
Does BIOMERICA INC (BMRA) stock pay dividends?
BMRA does not pay a dividend.
When does BIOMERICA INC (BMRA) report earnings?
BIOMERICA INC (BMRA) will report earnings on 2025-04-10.
What is the Price/Earnings (PE) ratio of BIOMERICA INC (BMRA)?
BIOMERICA INC (BMRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).
What is the Short Interest ratio of BIOMERICA INC (BMRA) stock?
The outstanding short interest for BIOMERICA INC (BMRA) is 1.56% of its float. Check the ownership tab for more information on the BMRA short interest.
BMRA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to BMRA. When comparing the yearly performance of all stocks, BMRA is one of the better performing stocks in the market, outperforming 95.81% of all stocks.
BMRA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BMRA. BMRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BMRA Financial Highlights
Over the last trailing twelve months BMRA reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 14.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.06% | ||
| ROE | -109.6% | ||
| Debt/Equity | 0 |
BMRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to BMRA. The Buy consensus is the average rating of analysts ratings from 7 analysts.